Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-17-015198
Filing Date
2017-03-16
Accepted
2017-03-16 18:52:37
Documents
1
Period of Report
2017-03-14

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v462045_4.html 4  
1 OWNERSHIP DOCUMENT v462045_4.xml 4 5492
  Complete submission text file 0001144204-17-015198.txt   7155
Mailing Address 155 GIBBS STREET SUITE 412 ROCKVILLE MD 20850
Business Address 617 DETROIT STREET, SUITE 100 ANN ARBOR MI 48104 (734) 332-7800
Synthetic Biologics, Inc. (Issuer) CIK: 0000894158 (see all company filings)

EIN.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3985 RESEARCH PARK DRIVE ANN ARBOR MI 48108
Business Address
Kraws Jeffrey J (Reporting) CIK: 0001380918 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-12584 | Film No.: 17695989